Trial intelligence / Profile preview

Effects of Systemic Isotretinoin Therapy on Choroidal Thickness and Retinal Vascular Parameters in Nodulocystic Acne Patients

NCT07675460Completed

Start
Apr 2024
Primary completion
Jul 2025
Countries
1
01

Overview

Open-label, single-arm trial of isotretinoin in acne vulgaris. Primary endpoint: Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0 at 24 weeks. Started Apr 2024; status: completed.

02

Drugs

isotretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT07675460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07675460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call